You can buy or sell Morphic and other stocks, options, ETFs, and crypto commission-free!
Morphic Holding, Inc. operates as a biopharmaceutical company, which engages in the research and development of oral small-molecule integrin therapeutics. It operates a Morphic integrin technology platform, MInT platform, to create a broad pipeline of programs across a variety of therapeutic areas. Read More The company was founded by Timothy A. Springer in August 2014 and is headquartered in Waltham, MA.
52 Week High
52 Week Low
— per share
Expected May 7, After Hours